Vitamin C 1000 mg

Vitamin C 1000 mg

Solaray4.8 (1,022 ratings)
Format:Capsule Quantity: 250 VegCap(s) · 250 servings
Goals
$31.99 $0.12 per serving

Product analysis

66 out of 100

Vitamin C 1000 mg supports normal immune function and collagen formation, particularly when vitamin C intake is low. Its added citrus mixture does not fully identify its individual contents, making the extras harder to compare.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Vitamin C sources and the citrus origin of the flavonoids are named. Their form quality remains uncertain, so the named sources do not establish an advantage over other vitamin C options.

Ingredient Transparency80

Both listed amounts and source forms are stated. The citrus mixture does not fully identify its individual contents, leaving part of the formula less clear.

Value For Money72

The serving compares favorably for the amount of vitamin C provided. The added flavonoid mixture has no clear value comparison of its own.

Customer Satisfaction83

Customers give it very positive ratings. A large number of ratings provides a broad view of customer satisfaction.

Product Focus76

Vitamin C provides a clear nutritional role in immune function and collagen formation. Broader skin, eye or inflammation benefits remain conditional and should not be expected simply from taking more vitamin C.

Format
Capsule
Container
250 VegCap(s)
Per serving
$0.12
Customer rating
4.8 · 1,022 ratings
Report analysis

Goals

Skin Health
Impact
High effect
B Ingredient FitF PathwaysA+ EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C helps form collagen and supports normal wound healing. Its clearest skin benefit is correcting low intake; extra vitamin C has not been shown to improve skin when intake is adequate. The declared form does not establish additional cosmetic benefit.

How this product is rated for Skin Health

Ingredient fit80

Skin-related ingredients are part of a broader formula. Disclosed amounts explain the retained findings, while unresolved ingredient facts limit additional conclusions.
Goal fit
Relevant skin ingredients appear in a broader formula with other actives, giving a partial focus on this goal.
Dose adequacy
Serving amounts provide the retained amount findings; larger amounts do not automatically mean greater skin benefit.

Pathways0

No selected structural, water-binding, barrier-lipid or UV-related pathway receives coverage in the saved findings.
Depth
No selected structural, water-binding, barrier-lipid or UV-related pathway receives coverage in the saved findings.
Breadth
None of the selected pathways reaches the coverage threshold.

Evidence100

Vitamin C leads the retained evidence finding, with a clear role in normal collagen formation and correcting low intake.
Evidence strength
Vitamin C leads the retained evidence finding, with a clear role in normal collagen formation and correcting low intake.
Studied preparation
Retained ingredients meet the preparation check, but the complete formula is not thereby established as equivalent to a skin trial.

Formulation logic100

No partner gaps or conflicts were identified. All retained ingredients meet the amount threshold, without establishing a proven daily skin-treatment regimen.
Partner coverage
The retained ingredients work independently or have their required partner, without demonstrated extra combination benefit.
Conflicts
No conflicts were identified by the evaluated ingredient checks.
Effective doses
All retained ingredients meet the amount threshold, without establishing a proven daily skin-treatment regimen.
Study evidence
Vitamin C Supportive 53 studies
Immunity
Impact
Highest effect
A Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C supports immune-cell activity and may modestly shorten colds with regular use, without establishing infection prevention or treatment of an established cold. The serving amount is compared with the saved reference, which does not establish an optimal dose or greater benefit at higher exposure.

How this product is rated for Immunity

Ingredient fit94

The counted amounts reach the saved comparison levels, without establishing an optimal intake or additional benefit above them.
Goal fit
The counted ingredients are focused on immunity, although the product may also relate to other goals.
Dose adequacy
The counted amounts reach the saved comparison levels, without establishing an optimal intake or additional benefit above them.

Pathways60

The strongest saved connection is innate immune cell activity, rather than a direct measure of infection protection.
Depth
The strongest saved connection is innate immune cell activity, rather than a direct measure of infection protection.
Breadth
The saved findings cover innate immune cell activity.

Evidence100

Vitamin C provides the leading saved contribution; its supported role does not establish infection prevention.
Evidence strength
Vitamin C provides the leading saved contribution; its supported role does not establish infection prevention.
Studied preparation
The saved findings accept the preparations with sufficient amounts; this does not establish testing of the complete formula.

Formulation logic100

All counted ingredients reach the saved minimum amount threshold, which is not proof of clinical effectiveness.
Partner coverage
The counted ingredients can contribute without an additional partner; this does not establish synergy.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All counted ingredients reach the saved minimum amount threshold, which is not proof of clinical effectiveness.
Study evidence
Vitamin C Supportive 53 studies
Everyday Health
Impact
High effect
B Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C supplies a nutrient involved in normal immune and antioxidant functions. The nutritional contributions are most useful when intake is low; extra benefit with adequate intake is not established.

How this product is rated for Everyday Health

Ingredient fit80

Vitamin C and the other relevant nutrients provide the main connection to general health. Additional actives make the formula less focused on this goal.
Goal fit
Relevant nutrients contribute to general health, alongside other actives with less direct support for this goal.
Dose adequacy
The relevant amounts reach the saved nutritional comparison endpoints; larger amounts do not establish greater benefit.

Pathways54

The strongest area is antioxidant and immune defence. Contributions also reach the saved coverage level across antioxidant and immune defence.
Depth
The strongest supported area is antioxidant and immune defence, through the relevant nutrient contributions.
Breadth
The supported areas reaching the saved coverage level are antioxidant and immune defence.

Evidence74

Vitamin C provides the strongest supported contribution. The supplied context limits routine expectations to filling nutritional gaps rather than improving outcomes in adequately nourished adults.
Evidence strength
Vitamin C provides the strongest supported contribution here; usefulness remains conditional on the relevant nutritional or population context.
Studied preparation
The relevant preparations match those recognized by the saved findings; this does not establish superiority of a form or delivery method.

Formulation logic100

The relevant ingredients can contribute independently, and no configured conflict was found. Their presence together does not establish an added combination benefit.
Partner coverage
The relevant ingredients can contribute independently or have their required partners present; no extra combination benefit is established.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All ingredients retained for contribution meet the saved amount threshold; that threshold does not prove a clinical benefit.
Study evidence
Vitamin C Supportive 56 studies
Impact
High effect
B Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C provides antioxidant functions, with limited inflammation evidence: the described trial was null overall, while CRP fell in participants with elevated starting levels. That conditional biomarker result does not establish broad clinical anti-inflammatory benefit. Its amount reaches the reviewed comparison without removing the baseline-inflammation limitation.

How this product is rated for Inflammation

Ingredient fit80

Vitamin C anchors the included contributions, with amounts reaching the comparison range.
Goal fit
Relevant nutrients sit within a broader formula, reducing its concentration on the inflammation-related roles considered here.
Dose adequacy
The declared amounts reach the comparison range; that does not establish a clinical anti-inflammatory effect.

Pathways55

The represented contribution centres on oxidative and mitochondrial stress. Coverage across the other specified routes is limited.
Depth
Oxidative and mitochondrial stress is the strongest represented route; the ingredient-specific clinical limitations still apply.
Breadth
One specified route reaches the required coverage; the other routes add limited breadth.

Evidence87

Vitamin C provides the strongest included finding. Biomarker and selected-population limitations constrain expected clinical effects.
Evidence strength
Vitamin C anchors the evidence finding, with inflammation-marker benefit limited to elevated baseline CRP in the described trial.
Studied preparation
The included preparations satisfy the supplied comparison, without removing their population or outcome limitations.

Formulation logic100

The included ingredients meet the amount and partner checks, with no specified conflict triggered.
Partner coverage
No required supporting partner is missing for the included ingredients.
Conflicts
None of the specified ingredient conflict checks was triggered.
Effective doses
The included ingredients meet the minimum amount comparison; it is not a proven clinical anti-inflammatory dose.
Study evidence
Vitamin C Supportive 50 studies
Impact
High effect
B Ingredient FitD PathwaysC+ EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C has a role in a defined AREDS combination for selected people with AMD. That combination evidence does not establish better routine vision from this ingredient alone, and the serving amount does not establish an equivalent clinical regimen.

How this product is rated for Eye Health

Ingredient fit80

The formula’s recognized ingredients, amount disclosure and broader uses determine its saved fit for vision support.
Goal fit
Other ingredients and uses broaden the formula beyond vision support, reducing its focus on this goal.
Dose adequacy
The declared quantity meets the saved amount comparison; this is not proof of an effective routine vision dose.

Pathways47

The saved routes describe composition and nutrient roles; they do not establish prevention or treatment of eye disease.
Depth
Retinal and lens antioxidant defense is the strongest saved route, without demonstrating a corresponding clinical vision improvement.
Breadth
Only one configured route reaches the coverage criterion, so the saved coverage is narrow.

Evidence68

The saved ingredient and preparation findings remain subject to the specific populations, combinations and visual outcomes in the supplied evidence.
Evidence strength
Vitamin C leads the saved evidence finding; that standing does not extend the supplied studies to general eye-disease prevention.
Studied preparation
The saved finding recognizes the preparations that meet its amount criterion; this does not establish equivalence to a complete AREDS regimen.

Formulation logic100

The recognized ingredients need no missing partner, and no specified conflict was triggered.
Partner coverage
No required partner is missing for the ingredients recognized by this comparison.
Conflicts
None of the specified conflicts was triggered in the supplied findings.
Effective doses
Every recognized ingredient reaches the minimum amount criterion; this is not a proven clinical vision-benefit threshold.
Study evidence
Vitamin C Disputed 24 studies

Ingredients

IngredientAmount per servingScore
Vitamin C (Acerola Cherry, Ascorbic Acid, Rose Hip)
1000 mg 61
Bioflavonoid Concentrate (Citrus)
50 mg
Adults 18–50
Report overview
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value
Each serving supplies 1000 mg of vitamin C, including ascorbic acid. The other source and its share are unresolved in the saved facts; the whole-product price equates to about $0.13 per 1,000 mg of vitamin C.
How this ingredient is rated

Active Ingredient Quality & Bioavailability30

Ascorbic acid is one identified form, while another source and the proportions are unresolved. The saved evaluation does not establish a buffering or stomach-friendly claim.
Vitamin C Chemical Form & Delivery System
Ascorbic acid is one identified form; another source and the proportions are unresolved in the saved facts.
Gastric Comfort & pH Balance
The saved evaluation does not establish whether the mixture is buffered or stomach-friendly.

Dose, Safety & Label Transparency83

The serving provides 1000 mg of vitamin C, while the complete source breakdown and proportions are unresolved.
Optimal Dosage Targeting
Each serving supplies 1000 mg of vitamin C, a substantial amount.
Purity & Excipient Quality
The evaluation did not flag the sweeteners, artificial colors or preservatives covered by its other-ingredient checks.
Mineral & Source Transparency
The vitamin C amount is known and ascorbic acid is identified, but another source and the proportions are unresolved.

Value80

Based on the whole-product price, the equivalent of 1,000 mg of vitamin C costs about $0.13.
Price per Gram of Vitamin C
Based on the whole-product price, the equivalent of 1,000 mg of vitamin C costs about $0.13.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies.
    Aune D; Keum N; Giovannucci E; Fadnes LT; Boffetta P; Greenwood DC; Tonstad S; Vatten LJ; Riboli E; Norat T · The American journal of clinical nutrition · 2019
    Meta-analysis69 studies pooledEveryday Health forVitamin C
  2. Scientific Opinion on the substantiation of a health claim related to vitamin C and increasing non haem iron absorption pursuant to Article 14 of Regulation (EC) No 1924/2006.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) · EFSA journal. European Food Safety Authority · 2026
    Guideline / consensusEveryday Health forVitamin C
  3. Vitamin C Depletion and All-Cause Mortality in Renal Transplant Recipients.
    Sotomayor CG; Eisenga MF; Gomes Neto AW; Ozyilmaz A; Gans ROB; Jong WHA; Zelle DM; Berger SP; Gaillard CAJM; Navis GJ; Bakker SJ · Nutrients · 2018
    Cohort study598 participantsEveryday Health forVitamin C
  4. Associations of Serum Biomarkers of Fruit and Vegetable Intake With the Risk of Cause-Specific Mortality and All-Cause Mortality: A National Prospective Cohort Study.
    Pu L; Zhang R; Wang X; Zhao T; Sun H; Han L · Frontiers in nutrition · 2022
    Cohort study12,530 participantsEveryday Health forVitamin C
  5. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition.
    Khaw KT; Bingham S; Welch A; Luben R; Wareham N; Oakes S; Day N · Lancet (London, England) · 2001
    Cohort study19,496 participantsEveryday Health forVitamin C
  6. Role of Oral Vitamin 'C' on Astigmatic Errors in Phacoemulsification.
    Mohan S; Sah K; Khattri M; Ahmad L; Sachan SK · Current eye research · 2021
    Randomized trial400 participantsEye Health forVitamin C
  7. Ascorbic acid metabolites are involved in intraocular pressure control in the general population.
    Hysi PG; Khawaja AP; Menni C; Tamraz B; Wareham N; Khaw KT; Foster PJ; Benet LZ; Spector TD; Hammond CJ · Redox biology · 2019
    Observational studyEye Health forVitamin C
  8. Nutritional modulation of cataract.
    Weikel KA; Garber C; Baburins A; Taylor A · Nutrition reviews · 2014
    Narrative reviewEye Health forVitamin C
  9. Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan.
    Aoki A; Inoue M; Nguyen E; Obata R; Kadonosono K; Shinkai S; Hashimoto H; Sasaki S; Yanagi Y · Scientific reports · 2017
    Case-control study530 participantsEye Health forVitamin C
  10. Adherence to a Mediterranean diet, lifestyle and age-related macular degeneration: the Coimbra Eye Study - report 3.
    Raimundo M; Mira F; Cachulo MDL; Barreto P; Ribeiro L; Farinha C; Laíns I; Nunes S; Alves D; Figueira J; Merle BM; Delcourt C; Santos L; Silva R · Acta ophthalmologica · 2019
    Case-control study883 participantsEye Health forVitamin C
  11. Vitamin C and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) · EFSA journal. European Food Safety Authority · 2026
    Guideline / consensusImmunity forVitamin C
  12. Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis.
    Sun L; Zhao JH; Fan WY; Feng B; Liu WW; Chen RQ; Ban C; Dang AG; Wang M; Luo KT; Zhou GY; Yu FF; Ba Y · Nutrition reviews · 2024
    Meta-analysis2,334 participants14 studies pooledImmunity forVitamin C
  13. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis.
    Abioye AI; Bromage S; Fawzi W · BMJ global health · 2021
    Meta-analysisImmunity forVitamin C
  14. New evidence for antioxidant properties of vitamin C.
    Vojdani A; Bazargan M; Vojdani E; Wright J · Cancer detection and prevention · 2001
    Randomized trial20 participantsImmunity forVitamin C
  15. Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults.
    Calder PC; Kreider RB; McKay DL · Nutrients · 2025
    Systematic review13 studies pooledImmunity forVitamin C
  16. Efficacy of Vitamin C as Glucocorticoid Substitute for Reducing Pain and Inflammation After Total Hip Arthroplasty: A Randomized Controlled Trial.
    Jiang W; Xu H; Jiang X; Zhan Y; Ju Y; Xie J; Huang Z; Huang Q; Pei F · The Journal of bone and joint surgery. American volume · 2025
    Randomized trial107 participantsInflammation forVitamin C
  17. The Impact of Vitamin C on Analgesic, Anti-inflammatory, and Hemostatic Outcomes After Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Moftakhari Hajimirzaei S; Bagherzadeh Cham M; Dolikhani M; Tabatabaee SM; Ebrahimpour A · The archives of bone and joint surgery · 2026
    Meta-analysis1,162 participants10 studies pooledInflammation forVitamin C
  18. The impact of vitamin C supplementation on the perioperative outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis.
    Liu X; Guo J; Li Y; Yang Y; Liu M; Gao Q; Yang Y; Wu X; Yue C · BMC musculoskeletal disorders · 2026
    Meta-analysis852 participants8 studies pooledInflammation forVitamin C
  19. Therapeutic Impact of Ascorbic Acid on Oral and Periodontal Tissues: A Systematic Literature Review.
    Ruzijevaite G; Acaite E; Jagelaviciene E · Medicina (Kaunas, Lithuania) · 2025
    Systematic review811 participants17 studies pooledInflammation forVitamin C
  20. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.
    Korantzopoulos P; Kolettis TM; Kountouris E; Dimitroula V; Karanikis P; Pappa E; Siogas K; Goudevenos JA · International journal of cardiology · 2005
    Randomized trial44 participantsInflammation forVitamin C